A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Native Chromatin Immunoprecipitation Using Murine Brain Tumor Neurospheres

7.1K views

⸱

DOI:

10.3791/57016

⸱

January 29th, 2018

 ,  ,  ,  , 

In This Article

Summary

Epigenetic mechanisms are frequently altered in glioma. Chromatin immunoprecipitation could be used to study the consequences of genetic alterations in glioma that result from changes in histone modifications which regulate chromatin structure and gene transcription. This protocol describes native chromatin immunoprecipitation on murine brain tumor neurospheres.

Abstract

Epigenetic modifications may be involved in the development and progression of glioma. Changes in methylation and acetylation of promoters and regulatory regions of oncogenes and tumor suppressors can lead to changes in gene expression and play an important role in the pathogenesis of brain tumors. Native chromatin immunoprecipitation (ChIP) is a popular technique that allows the detection of modifications or other proteins tightly bound to DNA. In contrast to cross-linked ChIP, in native ChIP, cells are not treated with formaldehyde to covalently link protein to DNA. This is advantageous because sometimes crosslinking may fix proteins that only transiently interact with DNA and do not have functional significance in gene regulation. In addition, antibodies are generally raised against unfixed peptides. Therefore, antibody specificity is increased in native ChIP. However, it is important to keep in mind that native ChIP is only applicable to study histones or other proteins that bind tightly to DNA. This protocol describes the native chromatin immunoprecipitation on murine brain tumor neurospheres.

Introduction

Epigenetic events are frequent in gliomas and likely play an important role in tumor pathogenesis. Indeed, in pediatric high-grade glioma, mutations in genes encoding histone variants H3.3 and H3.1 occur frequently1. The mutations affect histone modifications and have major epigenetic consequences2,3. In the adolescent to adult spectrum, recurrent mutations in isocitrate dehydrogenase gene 1/2 (IDH1/2), a mutation that inhibits α-KG dependent histone and DNA de-methylasaes, and genetic alterations in other chromatin regulators such as ATRX and DAXX occur4. T....

Access restricted. Please log in or start a trial to view this content.

Protocol

All methods described here have been approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Michigan.

1. Generation of brain tumor NS and culturing conditions.

  1. Prepare Neural Stem Cell Medium (NSC) with Dulbecco's Modified Eagle Medium/F12B27 supplement (1x), N2 supplement (1x), and an antimicrobial reagent. Supplement NSC medium on the day of use with human recombinant endothelial growth factor (EGF) and basic-fibroblast growth factor (FGF) at a final concentration of 20 ng/mL each.
  2. Induce the brain tumor in mouse using the Sleeping Beauty transposon system in which plasmids encod....

Access restricted. Please log in or start a trial to view this content.

Results

A schematic representation of tumor NS generated from a brain tumor where brain tumor cells are Katushka positive is presented in Figure 1. Figure 2 is a schematic representation of the entire ChIP technique. Figure 3 shows the representative results of chromatin from brain tumor NS digested with MNase for 12 min, yielding a majority of mono, di-, and tri- nucleosomes. Following ChIP, a qPCR may be p.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The protocol presented here will enable the user to perform native ChIP on NS derived from genetically engineered brain tumors. In contrast to cross-linking ChIP, this protocol is limited for the study of proteins that associate tightly with DNA6. The number of cells used can be modified as necessary and the protocol can be scaled up. We used 1 X 106 cells per IP, however, native ChIP may also be performed with as little as 4 x 104 cells5. In this prot.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS) Grants R37-NS094804, R01-NS074387, R21-NS091555 to M.G.C.; NIH/NINDS Grants R01-NS076991, R01-NS082311, and R01-NS096756 to P.R.L.; NIH/NINDS R01-EB022563; the Department of Neurosurgery; Leah's Happy Hearts, and Chad Though Foundation to M.G.C. and P.R.L. RNA Biomedicine Grant F046166 to M.G.C. F.M.M. is supported by an F31 NIH/NINDS-F31NS103500. R.I.Z.-V. is supported by the NIH/ NIGMS grant 5T34GM007821-37.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Agilent 2100 BioanalyzerAgilentG2946-90004bioanalyzer
AccuSpin Micro 17R, refrigeratedFisher Scientific13-100-676
C57BL/6TaconicB6-fC57BL/6 mouse
Calcium ChlorideAldrich22350-6buffer reagent
D-Luciferin, Potassium SaltGoldbioLuckK-1g
DiaMag1.5 magnetic rackDiagenodeB04000003for magnetic bead washes
DiaMag Rotator EUDiagenodeB05000001rotator
DMEM/F-12Gibco11330-057NSC component
Dynabeads Protein AThermo Fisher Scientific10001Dprotein A magnetic beads
Dynabeads Protein GThermo Fisher Scientific10003Dprotein G magnetic beads
EGFPeproTechAF-100-15prepare 20 μg/mL stock in 0.1% BSA and aliquot.
Ethylenediaminetetraacetic acid (EDTA)SigmaE-4884buffer reagent
ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid) (EGTA)SigmaE-4378buffer reagent
Fast SYBR Green Master MixApplied Biosystems4385612qPCR reagent
Fetal Bovine SerumGibco10437028for freezing cells
FGFPeproTech100-18bPrepare 20 μg/mL stock in 0.1% BSA and aliquot.
ForcepsFine Science Tools11008-13for dissection of tumor
Glycerol, MB GradeEMD- Millipore356352
H3K4me3AbcamAb8580
H3K27me3Millipore07-449
HBSSGibco14175-103balanced salt solution
FlurisoVETone501017inhalation anesthetic
Ivis SpectrumPerkin-Elmer124262in vivo optical imaging system
HyqtaseHyClonSV3003001cell detachment media
Lithium ChlorideSigmaL8895buffer reagent
Low binding microtubesCorning CostarCLS3207low protein binding microcentrifuge tube
Microcentrifuge tubeFisher21-402-903regular microcentrifuge tube
Micrococcal NucleaseThermo Fisher Scientific, Affymetrix70196Yeach batch may differ; purchase sufficient amount for experiments and aliquot.
N2Gibco17502-048NSC component
Normal Rabbit IgGMillipore12-372
NormocinInvivogenNOL-36-063anti-microbial agent, use at 0.1 mg/mL.
NP-40 (Igepal CA-630)Sigma18896-50MLbuffer reagent
Kimble Kontes Pellet PestleFisher ScientificK749515-0000
Protease Inhibitor CocktailSigma-AldrichP8340aliquot and store at -20 °C.
Protinase KSigma-AldrichP2308make 10 mg/mL stock in water; aliquot and store at -20 °C.
QIAquick PCR Purification KitQiagen28104DNA purification kit
ScalpelFine Science Tools10007-16for dissection of tumor
Sodium ChlorideVWR0241-5KGbuffer reagent
Sodium DeoxycholateSigma-AldrichD670-25Gbuffer reagent
Sodium Dodecyl sulfate (SDS)SigmaL-4390buffer reagent
Tris BaseThermo Fisher ScientificBp152-1buffer reagent
Triton X-100Thermo Fisher ScientificBP 151-500polyethylene glycol octylphenyl ether
Standard Mini CentrifugeFisherbrand12-006-901standard mini centrifuge
SZX16 microscopeOlympusSZX16flourescent dissecting microscope
ViiA 7 Real-Time PCR System with Fast 96-Well BlockApplied Biosystems4453535
Nanodrop OneThermo-Fisher ScientificND-ONEC-W

References

  1. Schwartzentruber, J., et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 482 (7384), 226-231 (2012).
  2. Bjerke, L., et al. Histone H3.3. mutations drive pediatric glioblastoma th....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Histone Mark EnrichmentMicrococcal Nuclease DigestionChromatin FragmentationProtein A G Magnetic BeadsRIPA Buffer WashesTE Buffer ElutionqPCR ValidationHistone Modifications